JP2001505219A - 創傷の治癒および線維症の治療 - Google Patents
創傷の治癒および線維症の治療Info
- Publication number
- JP2001505219A JP2001505219A JP52531898A JP52531898A JP2001505219A JP 2001505219 A JP2001505219 A JP 2001505219A JP 52531898 A JP52531898 A JP 52531898A JP 52531898 A JP52531898 A JP 52531898A JP 2001505219 A JP2001505219 A JP 2001505219A
- Authority
- JP
- Japan
- Prior art keywords
- wounds
- fibrosis
- wound
- gelsolin
- actin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.創傷または線維症の治療用医薬の製造における、細胞内および/または細 胞外においてアクチンの組み立ておよび組織化を調節する化合物の使用。 2.アクチンの組み立ておよび組織化を調節する化合物が、アクチンフィラメ ントを切断する請求項1に記載の使用。 3.化合物が、ゲルソリン、ビリン、CapG、アドセベリン、フライトレス −1およびアドビリンおよびその誘導体から選ばれる請求項2に記載の使用。 4.化合物が、ゲルソリンまたはその誘導体である請求項3に記載の使用。 5.瘢痕の形成を阻止または予防するための創傷の治療における、前記請求項 のいずれかに記載の使用。 6.眼神経組織または腸の瘢痕形成の阻止または予防における、請求項5に記 載の使用。 7.皮膚の瘢痕形成の阻止または予防における、請求項6に記載の使用。 8.火傷の後の瘢痕形成の阻止または予防における、請求項6に記載の使用。 9.創傷の治癒速度が増加するような創傷の治療における、請求項1〜4のい ずれか一つに記載の使用。 10.急性創傷の治療における、請求項9に記載の使用。 11.急性創傷が、刺し傷、火傷、電気的外科手術の結果生じる神経損傷また は創傷のいずれか一つである、請求項10に記載の使用。 12.慢性創傷の治療における、請求項9に記載の使用。 13.慢性創傷が、糖尿病性潰瘍形成、静脈潰瘍形成および床ずれ潰瘍形成な らびに一般に治癒が困難となっている個体の創傷のいずれか一つである、請求項 12に記載の使用。 14.線維症を予防または軽減における、請求項1〜4に記載のいずれか一つ に記載の使用。 15.線維症が、線維性疾患である、請求項14に記載の使用。 16.線維性疾患が、糸球体腎炎、肝硬変、肺線維症、成人呼吸困難症候群お よび線維細胞性疾患の一つである、請求項15に記載の使用。 17.治療上有効量の細胞内および/または細胞外においてアクチンの組み立 ておよび組織化を調節する化合物ならびに医薬的に許容しうるビヒクルを含む、 創傷または線維症の治療用組成物 18.アクチンの組み立ておよび組織化を調節する化合物が、アクチンフィラ メントを切断する請求項19に記載の組成物。 19.化合物が、ゲルソリン、ビリン、CapG、アドセベリン、フライトレ ス−1およびアドビリンおよびその誘導体から選ばれる請求項17または18に 記載の組成物。 20.化合物が、ゲルソリンまたはその誘導体である請求項19に記載の組成 物。 21.冒された組織に、細胞内および/または細胞外においてアクチンの組み 立ておよび組織化を調節する化合物を、治療上有効量にて、適用することを特徴 とする創傷または線維症の治療方法。 22.遺伝子治療技術に使用するためのデリバリーシステムであって、アクチ ンの組み立ておよび組織化を調節する化合物タンパク質をコードするDNA分子 を特徴とし、該DNA分子は、転写されて該タンパク質を発現する能力をもつ、 デリバリーシステム。 23.DNA分子が、ゲルソリン、ビリン、CapG、アドセベリン、フライ トレス−1およびアドビリンおよびその誘導体のひとつをコードする、請求項2 2に記載のデリバリーシステム。 24.創傷または線維症の治療における、請求項22または23に記載のデリ バリーシステムの使用。 25.治療を必要とする患者に、治療上有効量にて、請求項24または25に 記載のデリバリーシステムを投与することを特徴とする、創傷または線維症の治 療方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9625148.3A GB9625148D0 (en) | 1996-12-04 | 1996-12-04 | Wound healing |
US3211596P | 1996-12-05 | 1996-12-05 | |
US60/032,115 | 1996-12-05 | ||
US9625148.3 | 1996-12-05 | ||
PCT/GB1997/003243 WO1998024465A1 (en) | 1996-12-04 | 1997-12-04 | Wound healing and treatment of fibrosis |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001505219A true JP2001505219A (ja) | 2001-04-17 |
JP2001505219A5 JP2001505219A5 (ja) | 2005-07-14 |
Family
ID=26310539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52531898A Pending JP2001505219A (ja) | 1996-12-04 | 1997-12-04 | 創傷の治癒および線維症の治療 |
Country Status (12)
Country | Link |
---|---|
US (2) | US20020103112A1 (ja) |
EP (1) | EP0941108B1 (ja) |
JP (1) | JP2001505219A (ja) |
AT (1) | ATE226084T1 (ja) |
AU (1) | AU744750B2 (ja) |
CA (1) | CA2274002A1 (ja) |
DE (1) | DE69716460T2 (ja) |
DK (1) | DK0941108T3 (ja) |
ES (1) | ES2183220T3 (ja) |
HK (1) | HK1025732A1 (ja) |
PT (1) | PT941108E (ja) |
WO (1) | WO1998024465A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009512718A (ja) * | 2005-10-25 | 2009-03-26 | ウィミンズ アンド チルドレンズ ヘルス リサーチ インスティテュート | 創傷修復を調節するための方法及び組成物 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE307586T1 (de) * | 1998-08-13 | 2005-11-15 | Hadasit Med Res Service | Hemmung von mit gewebetrauma verbundenen pathogenen prozessen |
CA2388761A1 (en) * | 2001-06-18 | 2002-12-18 | Pfizer Inc. | Wound healing biomarkers |
US7301020B2 (en) * | 2003-06-19 | 2007-11-27 | Wisconsin Alumni Research Foundation | Macrolide analogs and methods for identifying same |
US9408891B2 (en) * | 2003-11-12 | 2016-08-09 | The Trustees Of The University Of Pennsylvania | Methods of using gelsolin to treat or prevent bacterial sepsis |
DK1694342T3 (da) * | 2003-11-12 | 2021-02-08 | Univ Pennsylvania | Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis |
KR101300929B1 (ko) * | 2004-05-12 | 2013-08-27 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 감염 치료를 위한 겔솔린의 용도 |
AU2006308431B2 (en) * | 2005-10-25 | 2011-11-10 | Adelaide Research & Innovation Pty Ltd | Methods and compositions for modulating wound repair |
ES2651619T3 (es) * | 2006-03-15 | 2018-01-29 | The Brigham And Women's Hospital, Inc. | Uso de gelsolina para tratar esclerosis múltiple y diagnosticar enfermedades neurológicas |
PL2001496T3 (pl) | 2006-03-15 | 2017-10-31 | Brigham & Womens Hospital Inc | Zastosowanie gelsoliny do diagnozowania i leczenia chorób zapalnych |
GB0724231D0 (en) * | 2007-12-12 | 2008-01-30 | Renono Ltd | Methods for inhibiting scarring |
PT2708603T (pt) | 2008-01-25 | 2017-07-20 | The Brigham And Women`S Hospital Inc | Utilizações em diagnóstico e terapia da gelsolina na insuficiência renal |
GB201003652D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Cardiff | Molecular target for healing or treating wounds |
EP3263121B1 (en) * | 2010-12-21 | 2019-02-27 | Leidos, Inc. | Methods and compositions for wound treatment |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929442A (en) | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
EP0280560B1 (en) | 1987-02-27 | 1994-05-11 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Membrane structure coated with low pI protein and methods of making and using |
US4950483A (en) * | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
AU663050B2 (en) | 1990-04-11 | 1995-09-28 | Brigham And Women's Hospital | Therapeutic uses of actin-binding compounds |
US5464817A (en) * | 1990-04-11 | 1995-11-07 | Brigham And Women's Hospital | Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I |
AU8647991A (en) | 1991-08-26 | 1993-03-16 | State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The | Keratinocyte-derived conditioned medium as a source of growth factors |
GB9206861D0 (en) * | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
GB2304047A (en) * | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
-
1997
- 1997-12-04 JP JP52531898A patent/JP2001505219A/ja active Pending
- 1997-12-04 WO PCT/GB1997/003243 patent/WO1998024465A1/en active IP Right Grant
- 1997-12-04 AU AU54010/98A patent/AU744750B2/en not_active Ceased
- 1997-12-04 ES ES97947761T patent/ES2183220T3/es not_active Expired - Lifetime
- 1997-12-04 CA CA002274002A patent/CA2274002A1/en not_active Abandoned
- 1997-12-04 PT PT97947761T patent/PT941108E/pt unknown
- 1997-12-04 EP EP97947761A patent/EP0941108B1/en not_active Expired - Lifetime
- 1997-12-04 DE DE69716460T patent/DE69716460T2/de not_active Expired - Lifetime
- 1997-12-04 AT AT97947761T patent/ATE226084T1/de active
- 1997-12-04 DK DK97947761T patent/DK0941108T3/da active
-
2000
- 2000-03-15 HK HK00101571A patent/HK1025732A1/xx not_active IP Right Cessation
-
2001
- 2001-09-26 US US09/962,604 patent/US20020103112A1/en not_active Abandoned
-
2006
- 2006-10-02 US US11/540,956 patent/US7566446B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009512718A (ja) * | 2005-10-25 | 2009-03-26 | ウィミンズ アンド チルドレンズ ヘルス リサーチ インスティテュート | 創傷修復を調節するための方法及び組成物 |
Also Published As
Publication number | Publication date |
---|---|
CA2274002A1 (en) | 1998-06-11 |
US7566446B2 (en) | 2009-07-28 |
HK1025732A1 (en) | 2000-11-24 |
PT941108E (pt) | 2003-01-31 |
ATE226084T1 (de) | 2002-11-15 |
AU5401098A (en) | 1998-06-29 |
US20020103112A1 (en) | 2002-08-01 |
WO1998024465A1 (en) | 1998-06-11 |
EP0941108B1 (en) | 2002-10-16 |
US20070087969A1 (en) | 2007-04-19 |
DE69716460D1 (de) | 2002-11-21 |
EP0941108A1 (en) | 1999-09-15 |
DE69716460T2 (de) | 2003-06-26 |
ES2183220T3 (es) | 2003-03-16 |
AU744750B2 (en) | 2002-02-28 |
DK0941108T3 (da) | 2002-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7566446B2 (en) | Wound healing and treatment of fibrosis | |
JP4994533B2 (ja) | コネキシンに対するアンチセンスヌクレオチドを含む配合物 | |
WO1998036061A2 (en) | Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity | |
US20070154448A1 (en) | Methods and compositions using Substance P to promote wound healing | |
JP4307561B2 (ja) | 創傷の治癒 | |
JP2012211185A (ja) | 創傷治癒のためのil−10関連ペプチド | |
TWI720582B (zh) | VEGF和TGFβ的多激酶抑制劑及其用途 | |
JP6640311B2 (ja) | 軟骨細胞の細胞外基質由来ペプチド | |
JPH09510967A (ja) | 創傷の治癒 | |
US20110059896A1 (en) | Use of furin convertase inhibitors in the treatment of fibrosis and scarring | |
US7713933B2 (en) | Pharmaceutical composition containing an activin or inhibin stimulator | |
Olmos-Zuñiga et al. | Effects of pirfenidone and collagen-polyvinylpyrrolidone on macroscopic and microscopic changes, TGF-β1 expression, and collagen deposition in an experimental model of tracheal wound healing | |
CA2304956A1 (en) | Pharmaceutical composition for preventing or treating ischemic diseases | |
JPH01279840A (ja) | 新規外用組成物 | |
CN117042773A (zh) | Chk2抑制剂的用途 | |
CN117042774A (zh) | 眼部病况的治疗 | |
WO2000010592A2 (en) | Medicaments for preventing or reducing scarring | |
EP1994929A1 (en) | Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041117 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080212 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080509 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080616 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080602 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080714 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080711 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080818 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080808 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081111 |